Common blood thinner for pregnant women proven ineffective

24 julio 2014

A daily injection to the belly commonly prescribed for pregnant women at risk of developing blood clots is found to be ineffective. As many as one in 10 pregnant women have a tendency to develop blood clots in their veins, a condition called thrombophilia. The anticoagulant LMWH has been prescribed for two decades to prevent related pregnancy complications. Now, a study provides conclusive evidence that it has no positive benefits for the mother or child, and could actually cause pregnant women some minor harm.